A case of transfusion-related acute lung injury induced by anti-human leukocyte antigen antibodies in acute leukemia

3Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

Abstract

Transfusion-related acute lung injury (TRALI) is a noncardiogenic pulmonary edema that occurs during or within 6 hours after transfusion. Risk factors for TRALI, which is relatively common in critically ill patients, include recent surgery, hematologic malignancy, and sepsis. Here, we report a case of TRALI induced by anti-human leukocyte antigen (anti-HLA) class II antibodies (HLA-DR) occurring after transfusion of platelet concentrates in a patient with acute leukemia. Although most patients with TRALI show improvement within 48?96 hours, our patient's condition rapidly worsened, and he did not respond to supportive treatment. TRALI is a relatively common and serious adverse transfusion reaction that requires prompt diagnosis and management. © 2012 Korean Society of Hematology.

Cite

CITATION STYLE

APA

Jin, S. M., Jang, M. J., Huh, J. Y., Park, M. H., Song, E. Y., & Oh, D. (2012). A case of transfusion-related acute lung injury induced by anti-human leukocyte antigen antibodies in acute leukemia. Korean Journal of Hematology, 47(4), 302–306. https://doi.org/10.5045/kjh.2012.47.4.302

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free